热门资讯> 正文
沃尔格林将支付1.068亿美元来解决司法部超额计费的索赔
2024-09-14 03:42
- 沃尔格林-联合博姿(WBA) 0
- 高宏集团(COWN) 0
- 易康(EHTH) 0
- The U.S. Department of Justice announced Friday that Walgreens Boots Alliance (NASDAQ:WBA) has agreed to pay $106.8M to settle its allegations that the pharmacy chain operator billed government health care programs for prescriptions it never dispensed.
- The alleged violations took place between 2009 and 2020 when Walgreens (WBA) submitted false claims for payments to Medicare, Medicaid, and other federal healthcare programs.
- The DoJ alleged that the Deerfield, Illinois, company obtained payments twice after restocking and reselling prescriptions it processed for federal health care programs, but their beneficiaries never picked up.
- “As a result, Walgreens received tens of millions of dollars for prescriptions that it never actually provided to health care beneficiaries,” the agency added.
- “This settlement marks another major achievement in our ongoing commitment to combat healthcare fraud,” said Roger B. Handberg U.S. Attorney for the Middle District of Florida.
More on Walgreens Boots Alliance
- Walgreens Boots Alliance, Inc. (WBA) TD Cowen 9th Annual FutureHealth Conference (Transcript)
- Walgreens: Short Interest Surge Indicates It's Time To Cut Your Losses
- Walgreens Is Imploding: Value Stock Or Value Trap?
- Walgreens, Hims stocks drop as Lilly rolls out cheap weight-loss drugs
- Retailers charge cash-back fees to consumers on smaller supply of free cash access points: CFPB
推荐文章
风险及免责提示：以上内容仅代表作者的个人立场和观点，不代表华盛的任何立场，华盛亦无法证实上述内容的真实性、准确性和原创性。投资者在做出任何投资决定前，应结合自身情况，考虑投资产品的风险。必要时，请咨询专业投资顾问的意见。华盛不提供任何投资建议，对此亦不做任何承诺和保证。
